Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Investment

Arkema invests in 3-D printing polymer firm Adaptive3D

by Craig Bettenhausen
November 8, 2020 | A version of this story appeared in Volume 98, Issue 43

 

Arkema has led a series B financing round for the 3-D printing polymer maker Adaptive3D. Arkema supplies some of the raw materials for Adaptive3D’s one-part, light-cured resins, which are sold into markets including health care, oil and gas, and transportation. West Pharmaceutical Services and Clear Fir Partners also participated in the series B round, as did the venture capital arm of the chip manufacturing equipment firm Applied Materials. Applied co-led Adaptive3D’s series A with DSM.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.